There has been a “significant” increase in throat cancers in men in the last 20 years related to HPV, a national coalition ...

Incidence rates are rising for HPV-related throat cancers, according to the American Cancer Society, particularly in men over the age of 55. Here's what to know.

The "Head and Neck Cancer Therapeutics Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032" report has ...

Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...

Diagnostics startup Droplet Biosciences is collaborating with chipmaker Nvidia to expedite post-surgery cancer test results using AI infrastructure.

Tonsil cancer related to HPV, often called oropharyngeal cancer, has been rising steadily over the past decade.

Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure.

Human papillomavirus (HPV), often associated only with cervical cancer, affects everyone—men included. Experts warn that HPV is increasingly linked to cancers in men, particularly oropharyngeal ...

The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for subcutaneous Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as a monotherapy for adults with advanced ...

FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.